pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
RISING · news · pharmadog
← back to RISING
News mentioning RISING
268
stories
Aug 18, 26
Opinion: In parts of the world, antibiotic overuse isn’t the problem — underuse is
stat
Aug 17, 26
‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensions
fiercebiotech
Aug 14, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Aug 14, 26
Opinion: U.S., U.K. health care systems share a fatal flaw
stat
Aug 14, 26
Nascent US psychedelic therapy opportunity attracts overseas manufacturers
biospace
Aug 12, 26
Vaping and cannabis hit record highs among young adults in 2025: Survey
stat
Aug 12, 26
WHO says Trump’s latest vaccine policy order is misguided
stat
Aug 12, 26
Opinion: Climate change is making people with chronic illness even sicker
stat
Aug 11, 26
Building Resilience for the Future of Biopharma Innovation
fiercebiotech
Aug 11, 26
After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’
biospace
Aug 11, 26
IRBs have a problem. Can North Star’s nonprofit model save it?
stat
Aug 11, 26
Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
stat
Aug 10, 26
Trump returns to controversial vaccine policy with order questioning childhood schedule
stat
Aug 10, 26
From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing
biospace
Aug 7, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Aug 7, 26
2026 Q2 Job Market Report: Job postings keep rising as fewer companies cut employees
biospace
Aug 7, 26
STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?
stat
Aug 6, 26
STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts
stat
Aug 6, 26
LifeMine raises $263M in mission to improve organ transplant aftercare
biospace
Aug 5, 26
STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
stat
Aug 5, 26
‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E
fiercebiotech
Aug 5, 26
Opinion: Tear down the wall between M.D. and D.O. education
stat
Aug 5, 26
STAT+: Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds
stat
Aug 4, 26
Novo dips 6% on Wegovy pill stumble despite Q2 earnings beat
biospace
Aug 4, 26
STAT+: The latest orphan drug exemptions may not be warranted, analysis finds
stat
Aug 4, 26
Smith & Nephew cuts 2026 outlook as US knee implant sales slide
fiercebiotech
Aug 4, 26
Latigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx
fiercebiotech
Aug 3, 26
BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech
biospace
Aug 3, 26
STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
stat
Aug 3, 26
BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger
fiercebiotech
← prev
page 5 of 9
next →
